Telehealth FX Talk - TelehealthFX.com

Telehealth FX
  • 0.0 (0)
  • Health & Fitness
  • Updated Daily

Welcome to TelehealthFX Talk, the evidence-based podcast that cuts through the hype of the rapidly evolving world of clinical weight loss and metabolic medicine.Whether you are navigating the transition to GLP-1 medications like semaglutide and tirzepatide, exploring complementary therapies like sermorelin and NAD+, or looking for natural metabolic support with berberine, we provide the honest, research-backed science you need to make informed decisions. Each week, we break down complex topics—from managing side effects and breaking through weight loss plateaus to preserving lean muscle mass and understanding the latest FDA updates.It is time to silence the food noise and optimize your metabolic health. Hit subscribe to stay up-to-date with the latest breakthroughs in clinical wellness, and visit us at telehealthfx.com to learn more about our comprehensive clinical programs.

  1. Sep 20

    The Top Tirzepatide Clinics: Why You Must Follow the "Both Protocol"

    Take the free GLP-1 qualification quiz at https://telehealthfx.com — TelehealthFX offers the 'Both Protocol': seamless access to both compounded semaglutide and compounded tirzepatide under one roof so you never get trapped at a metabolic weight loss plateau. If you are researching modern medical weight loss options like Zepbound and Mounjaro, you know that tirzepatide is widely regarded as the most potent peptide therapy available today. Because it activates both GLP-1 and GIP receptors simultaneously, clinical trials consistently demonstrate superior total fat loss compared to single-agonist medications. However, when evaluating online weight loss clinics, patients run into a frustrating bottleneck: many popular platforms don't offer tirzepatide at all—they exclusively sell semaglutide. In Episode 40 of TelehealthFX Talk, our clinical hosts explain why signing up with a single-medication clinic artificially caps your long-term success. We break down the biological inevitability of the six-month weight loss plateau, the friction of switching providers mid-treatment, and why following the 'Both Protocol' from day one is the smartest way to safeguard your metabolic transformation. WHAT WE COVER IN THIS EPISODE: 1. THE SEMAGLUTIDE-ONLY CORPORATE TRAP Why do so many telehealth platforms avoid compounded tirzepatide? It comes down to raw API costs and dose-tiering logistics. Sourcing high-purity tirzepatide is significantly more expensive for compounding pharmacies. To protect margins and avoid tiered pricing, mass-market platforms run a semaglutide-only factory. If you sign up with one of these clinics, your long-term options are restricted from day one. 2. THE INEVITABLE SIX-MONTH METABOLIC PLATEAU Semaglutide is fantastic for initial progress, helping patients drop their first 20 to 30 pounds. But eventually, mammalian biology adapts. In a prolonged caloric deficit, your body downregulates metabolic rate. Once you reach the maximum dose of semaglutide and hit a biological plateau, a semaglutide-only clinic has exhausted its clinical toolbox. They keep billing you monthly, but the scale refuses to move. 3. THE FRICTION OF SWITCHING CLINICS MID-TREATMENT To break through a stubborn plateau, upgrading to a dual-agonist (tirzepatide) to recruit the GIP receptor is often clinically necessary. But if your provider doesn't dispense it, you are forced to cancel your subscription, hunt down a new clinic, pay a second intake fee, repeat intake with new doctors, and wait weeks for a new pharmacy. This administrative friction causes countless patients to abandon treatment altogether. 4. THE 'BOTH PROTOCOL' SOLUTION The 'Both Protocol' is simple: only partner with a telehealth provider that maintains established US compounding pharmacy supply chains for BOTH semaglutide and tirzepatide before your first injection. This empowers you to start on cost-effective semaglutide for initial weight loss. Then, if your progress stalls, your provider seamlessly upgrades your protocol to tirzepatide within the exact same patient portal—no extra fees, no new paperwork, and no disruption to your treatment. 5. METABOLIC ADJUNCTS: PROTECTING LEAN MUSCLE & ENERGY Because dual-agonists trigger rapid fat loss, patients face elevated risks of muscle wasting (sarcopenia) and fatigue. TelehealthFX pairs incretin therapies with metabolic adjuncts: subcutaneous NAD+ injections to restore mitochondrial energy, and Sermorelin to naturally stimulate growth hormone and preserve lean muscle mass. THE TELEHEALTHFX ADVANTAGE: - Complete 'Both Protocol' (Semaglutide & Tirzepatide Available) - Seamless Protocol Pivoting Without Switching Clinics - 100% FDA-Registered US 503A Compounding Pharmacies - Dedicated 24-Hour Licensed Medical Provider Review - Fast 2-Day UPS Cold-Chain Shipping - Access to Muscle-Preserving Adjuncts (NAD+ & Sermorelin) OFFICIAL LINKS: Qualification Quiz: https://go.telehealthfx.com/start Berberine Options: https://go.telehealthfx.com/berberine Official Website: https://telehealthfx.com TIMESTAMPS: 0:00 - Introduction: The Problem with Single-Medication Clinics 1:20 - The Semaglutide-Only Trap: Profit Margins vs Care 2:40 - The Biology of the 6-Month Weight Loss Plateau 3:50 - The Friction of Switching Clinics Mid-Treatment 4:55 - The 'Both Protocol': Strategic Planning from Day One 6:10 - Metabolic Adjuncts: NAD+ & Sermorelin 7:15 - How to Access Both Semaglutide and Tirzepatide MEDICAL DISCLAIMER: Educational only. Consult a physician before starting prescription GLP-1 medications. Results vary. #TopTirzepatideClinics #BothProtocol #ZepboundAlternative #MounjaroAlternative #GLP1WeightLoss #SemaglutidePlateau #TelehealthFX #CompoundedTirzepatide #WeightLossTelehealth #AffordableGLP1 #MedicalWeightLoss #DualAgonist #PeptideTherapy #NADTherapy #Sermorelin #NoHiddenFees #HealthyLivingOnline

  2. Sep 20

    The 10 Best Online Semaglutide Providers (How to Spot the Scams)

    Take the free GLP-1 qualification quiz at https://telehealthfx.com — see if you're eligible for compounded semaglutide or tirzepatide delivered to your doorstep with all-inclusive pricing, zero hidden fees, and no long-term contracts. Are you overwhelmed trying to pick the right weight loss clinic from the dozens of 'Top 10 Online Semaglutide Providers' lists floating around the internet? You're not alone. The digital health space is crowded with massive brands like Ro, Hers, Sequence, and Found. But behind the multi-million-dollar ad campaigns lies a frustrating reality: most patients haven't been given the clinical criteria needed to separate high-standard medical care from predatory subscription traps. In Episode 39 of TelehealthFX Talk, our clinical team breaks down the 'Four-Pillar Evaluation Framework.' This is the exact, objective test you should use to audit any telehealth clinic before handing over your credit card or beginning medical treatment. WHAT WE COVER IN THIS EPISODE: PILLAR 1: PRICING TRANSPARENCY (THE 'ALL-IN' TEST) Does the advertised monthly price actually cover your prescription medication, or is it just a digital fee to access an app? Many high-profile platforms advertise teaser rates like $99 or $145 a month. Once you register, they send a prescription to your local retail pharmacy. When your commercial insurance denies coverage, you're hit with an unexpected $1,000+ pharmacy bill. Other platforms use deceptive dose tiering, doubling your price when you need therapeutic doses. A legitimate provider offers flat-rate, all-inclusive pricing where the consultation, ongoing clinical support, and compounded medication are bundled into one clear monthly cost. PILLAR 2: CLINICAL FLEXIBILITY (THE 'STEP THERAPY' TEST) Does the platform force you through mandatory step therapy before granting access to modern GLP-1s? Multiple prominent telehealth services require patients to fail on older, cheaper oral cocktails (like bupropion or topiramate) for months before they will prescribe semaglutide. If your bloodwork shows you are clinically indicated for a GLP-1, you deserve direct access from day one, without being forced to take generic pills that fail to address metabolic resistance. PILLAR 3: PROVIDER ACCESS (THE 'BOTTLENECK' TEST) When a platform scales rapidly with private equity capital, medical staff is frequently overwhelmed. If you experience severe nausea or gastrointestinal discomfort on a Saturday morning, you cannot wait four days for an automated helpdesk ticket. You are taking a potent, biologically active hormone. You need responsive, licensed clinical oversight. Look for clinics guaranteeing 24-hour medical review with real doctors and nurse practitioners, not automated chatbots. PILLAR 4: PHARMACY SOURCING (THE 'STERILITY' TEST) Where is your medication actually compounded? Never purchase grey-market 'research peptides' or unmixed powders requiring home reconstitution with bacteriostatic water. These products bypass sterile filtration and risk severe bacterial contamination. Reputable clinics partner exclusively with state-licensed, FDA-registered 503A compounding pharmacies adhering to strict USP standards, conducting third-party potency/endotoxin testing, and shipping via temperature-monitored cold-chain UPS. THE TELEHEALTHFX ADVANTAGE: TelehealthFX was engineered by examining the major pitfalls of large telehealth brands and delivering a patient-first model: - 100% Flat-Rate All-Inclusive Pricing (No Hidden Fees) - Direct Access to Semaglutide & Tirzepatide (No Forced Step Therapy) - Responsive 24-Hour Licensed Medical Provider Review - Licensed US 503A Compounding Pharmacies (Cold-Chain 2-Day Shipping) - All Injection Supplies Included (Syringes, Alcohol Wipes, Disposal Info) - Access to Metabolic Adjuncts (NAD+ Injections & Sermorelin) OFFICIAL LINKS: Qualification Quiz: https://go.telehealthfx.com/start Berberine Options: https://go.telehealthfx.com/berberine Official Website: https://telehealthfx.com TIMESTAMPS: 0:00 - Introduction: The Problem with Top 10 Provider Lists 1:15 - Pillar 1: Pricing Transparency & Membership Traps 2:45 - Pillar 2: Clinical Flexibility vs Forced Step Therapy 4:00 - Pillar 3: Provider Bottlenecks & 24-Hour Support 5:20 - Pillar 4: Pharmacy Sourcing & 503A Safety 6:35 - How TelehealthFX Passes the 4-Pillar Test 7:30 - How to Get Started with Legitimate GLP-1 Care MEDICAL DISCLAIMER: Educational only. Consult a physician before starting prescription GLP-1 medications. Results vary. #BestSemaglutideOnline #OnlineWeightLoss #SemaglutideProviders #GLP1WeightLoss #TelehealthFX #CompoundedSemaglutide #Top10Semaglutide #AffordableGLP1 #MedicalWeightLoss #NoHiddenFees #TelehealthReview #WeightLossJourney #HealthyLiving #OzempicAlternative #WeightLossGoals #TelehealthMedicine #PeptideTherapy #GLP1Medication #ClinicalCareFit

  3. Sep 20

    The Cheapest Tirzepatide Online: Why Does It Cost More Than Semaglutide?

    Take the free GLP-1 qualification quiz at https://telehealthfx.com — see if you're eligible for compounded tirzepatide or semaglutide delivered straight to your door with zero hidden fees and no long-term contracts. Why is tirzepatide so much more expensive than semaglutide? If you are researching medical weight loss options like Zepbound and Mounjaro, you know that tirzepatide is widely considered the heavy hitter of modern peptide therapy. However, patients shopping online for compounded options are often caught off guard by higher price tags and dose tiering structures compared to first-generation GLP-1 medications. In Episode 38 of TelehealthFX Talk, our clinical team breaks down the biochemical, manufacturing, and economic reality behind the 'Tirzepatide Premium.' We explain why this revolutionary dual-agonist peptide costs more to synthesize, why legitimate 503A compounding pharmacies use dose tiering, and the exact clinical strategies—like the 'Lowest Effective Dose Protocol'—that empower you to achieve maximum fat loss while saving hundreds of dollars each month. WHAT WE COVER IN THIS EPISODE: 1. THE BIOCHEMISTRY: SINGLE AGONIST VS. DUAL AGONIST Semaglutide targets a single incretin hormone receptor: GLP-1. Tirzepatide is a novel dual-agonist that activates both GLP-1 and GIP receptors simultaneously. GIP amplifies insulin sensitivity in adipose tissue, accelerates glucose clearance, and suppresses hunger signals in the brain. Clinical trials show that adding GIP significantly reduces nausea compared to semaglutide monotherapy. 2. SURMOUNT VS. STEP CLINICAL TRIAL OUTCOMES In clinical trials, semaglutide patients achieved an average of ~15% total body weight reduction over 68 weeks. In contrast, the landmark SURMOUNT-1 trial demonstrated that patients on therapeutic doses of tirzepatide achieved an average weight loss exceeding 20%, with over a third shedding more than 25% of body weight. You are paying for a measurably superior metabolic mechanism. 3. THE RAW API COST & WHY DOSE TIERING EXISTS Compounding pharmacies must source certified Active Pharmaceutical Ingredients (API) meeting USP monographs. Synthesizing a 39-amino-acid dual-agonist peptide requires advanced synthesizers, intensive purification, and sterility testing. A 15mg vial requires six times the raw peptide mass of a 2.5mg vial. Reputable 503A pharmacies physically cannot offer an arbitrary flat rate across high doses without incurring losses. 4. THE 'LOWEST EFFECTIVE DOSE' MONEY-SAVING BLUEPRINT Because tirzepatide is so potent, you do not need to rush to the maximum 15mg dose! If you are losing 1 to 2 pounds per week on a 5mg dose with zero food noise, stay on that dose. TelehealthFX providers partner with you to keep you on the lowest effective dose. This saves substantial money each month, protects metabolic rate, minimizes digestive side effects, and leaves valuable titration runway. 5. DANGERS OF UNREGULATED 'RESEARCH CHEMICAL' PEPTIDES Because authentic compounded tirzepatide carries a premium, grey-market websites sell unregulated vials labeled 'For Research Purposes Only' for $100 to $150. These illicit powders bypass FDA sterile filtration and endotoxin screens. Injecting unverified grey-market peptides risks severe bacterial infections, sterile abscesses, and systemic toxicity. Always demand accredited 503A US pharmacies. 6. THE TELEHEALTHFX SEAMLESS DUAL-PATHWAY PROTOCOL If you want to optimize your budget, begin your weight loss journey on affordable compounded semaglutide to drop your initial 20-30 pounds. If you hit an unavoidable metabolic plateau, TelehealthFX allows you to upgrade seamlessly to tirzepatide within the same patient portal—no second intake fee, no restarting paperwork, and no doctor switching. THE TELEHEALTHFX ADVANTAGE: - 100% Licensed US 503A Compounding Pharmacies - Transparent Dose Tiering with No Hidden Fees - 24-Hour Licensed Medical Provider Review - Fast 2-Day UPS Cold-Chain Shipping - Full Injection Kit Included - Access to NAD+ & Sermorelin OFFICIAL LINKS: Qualification Quiz: https://go.telehealthfx.com/start Berberine Options: https://go.telehealthfx.com/berberine Official Website: https://telehealthfx.com TIMESTAMPS: 0:00 - Introduction 1:15 - Biochemistry: GLP-1 vs GIP 2:30 - SURMOUNT-1 vs STEP Trials 3:45 - API Costs & Dose Tiering 4:50 - Lowest Effective Dose Strategy 5:55 - Grey-Market Research Peptides 6:45 - Dual-Pathway Protocol & Adjuncts 7:30 - Transparent Pricing MEDICAL DISCLAIMER: Educational only. Consult a physician before starting prescription GLP-1 medications. Results vary. #Tirzepatide #Semaglutide #Zepbound #Mounjaro #GLP1WeightLoss #CompoundedTirzepatide #TelehealthFX #WeightLossJourney #MedicalWeightLoss #TirzepatideCost #AffordableGLP1 #PeptideTherapy #SURMOUNT1 #DualAgonist #NoHiddenFees #HealthyLiving #WellnessGoals #HealthSOP #Fit

  4. Sep 16

    Mounjaro vs. Ozempic: Which Name-Brand GLP-1 Actually Works Better? (2026 Data)

    Take the free GLP-1 qualification quiz at https://go.telehealthfx.com/start — see if you're eligible for semaglutide or tirzepatide, the same active ingredients behind Ozempic and Mounjaro, delivered to your door with no hidden membership fees. Learn more at https://telehealthfx.com or explore berberine options at https://go.telehealthfx.com/berberine.   Mounjaro vs. Ozempic — everyone's asking which GLP-1 actually wins. In this episode of TelehealthFX Talk, we break down what the real clinical data says about tirzepatide (Mounjaro) versus semaglutide (Ozempic), including the SURPASS-2 head-to-head trial, the mechanism difference that explains the weight loss gap, and why the "which one's better" question isn't as simple as the headlines make it sound.   What we cover in this episode: - The core mechanism difference: Ozempic activates one receptor (GLP-1), Mounjaro activates two (GLP-1 and GIP) - SURPASS-2 trial results — the largest head-to-head comparison between tirzepatide and semaglutide - Why weight loss percentage comparisons you see online often mix different trial populations - An honest look at side effects — nausea, vomiting, diarrhea, and constipation rates for both drugs - Serious risk warnings shared by both medications: pancreatitis, gallbladder events, and thyroid C-cell signals - Why Ozempic carries FDA approval for cardiovascular and kidney risk reduction that Mounjaro doesn't yet have - Clearing up the brand confusion: Ozempic/Wegovy are semaglutide, Mounjaro/Zepbound are tirzepatide - Why a licensed provider — not a comparison chart — should guide your choice between the two   Whether you're just starting to research GLP-1 medications or trying to decide between semaglutide and tirzepatide, this episode gives you the clinical context behind the two biggest names in weight loss medication today.   TelehealthFX connects you with the same active ingredients found in Mounjaro and Ozempic — tirzepatide and semaglutide — through licensed U.S. compounding pharmacies, with 24-hour provider review, 2-day UPS shipping, and 1-on-1 onboarding support. No hidden membership fees. No confusing pricing tiers. Just transparent access to clinical weight loss support, licensed in all 50 states.   Program highlights: - Semaglutide and tirzepatide available through one platform - 24-hour provider review after you complete the qualification quiz - 2-day UPS shipping straight to your door - Licensed US compounding pharmacies - 1-on-1 onboarding support to help you get started with confidence - Transparent pricing with no hidden membership fees - Licensed in all 50 states - NAD+ and sermorelin also available for those exploring broader wellness support   Common questions this episode answers: - Is Mounjaro really more effective than Ozempic, or is that just marketing? - Why do Mounjaro and Ozempic have different side effect reputations if the data says they're similar? - Can you switch from Ozempic to Mounjaro, or vice versa? - What's the actual difference between Ozempic and Wegovy, or Mounjaro and Zepbound? - Does insurance coverage tell you anything about which drug is clinically better? (Short answer: no.) - Why does a GLP-1 medication that works well for one person not work the same way for someone else?   Choosing between semaglutide and tirzepatide isn't about picking the "winning" drug off a chart — it's about matching the medication to your own health history, tolerance, and goals, with a licensed provider guiding the process. That's the gap TelehealthFX is built to close: real clinical support, without the brand-name price tag or the guesswork.   Take the quiz at https://go.telehealthfx.com/start to see which option might be the right fit for your goals, or visit https://telehealthfx.com to learn more about how the program works. If you're curious about natural alternatives alongside or instead of GLP-1 medication, check out https://go.telehealthfx.com/berberine.   This podcast is for educational purposes only and does not constitute medical advice. Individual results vary. Always consult a licensed healthcare provider before starting, stopping, or switching any weight loss medication. Mounjaro and Ozempic are registered trademarks of their respective manufacturers; TelehealthFX is not affiliated with Eli Lilly or Novo Nordisk.   #GLP1 #WeightLoss #Semaglutide #Tirzepatide #OzempicAlternative #TelehealthWeightLoss #TelehealthFX #CompoundedSemaglutide #WeightLossMedication #Mounjaro #Ozempic #Zepbound #Wegovy #ClinicalWeightLoss #WeightManagement #FatBurning #DietPill #InsulinResistance #GLP1ForWeightLoss #WeightLossDelivered #RapidFatLoss #WeightLossForWomen #WeightLossForSeniors #TirzepatideVsSemaglutide #MounjaroVsOzempic #GLP1Comparison #WeightLossJourney #TelehealthMedicine #NADTherapy #Sermorelin

  5. Sep 16

    Wegovy vs. Zepbound: The Name-Brand GLP-1 Showdown — Which One Actually Wins in 2026?

    Take the free GLP-1 qualification quiz at https://go.telehealthfx.com/start — see if you're eligible for semaglutide or tirzepatide, delivered to your door with no hidden membership fees. Learn more at https://telehealthfx.com or explore berberine options at https://go.telehealthfx.com/berberine.   Wegovy and Zepbound are the two biggest names in GLP-1 weight loss medication, and for the first time, we actually have head-to-head trial data comparing them directly. In this episode of TelehealthFX Talk, we break down the SURMOUNT-5 head-to-head trial results, the real difference between semaglutide (Wegovy) and tirzepatide (Zepbound), and why the drug with more average weight loss isn't automatically the right choice for every person.   What we cover in this episode: - The SURMOUNT-5 head-to-head trial results and what the percentages mean in real pounds - Why Zepbound's dual GIP/GLP-1 mechanism tends to outperform Wegovy's single-receptor approach - The honest side-effect comparison — nausea, vomiting, diarrhea, and constipation rates - Why Wegovy's cardiovascular outcomes data (the SELECT trial) matters for heart disease patients - The new oral Wegovy pill and Wegovy HD, and what they mean for needle-averse patients - Shared contraindications to know before starting either medication - Why a licensed provider — not a search result — should make the final call   TelehealthFX offers a straightforward path to both semaglutide and tirzepatide, along with NAD+ and sermorelin, all backed by real clinical support. No hidden membership fees. No confusing contracts. Just transparent pricing, a 24-hour provider review, licensed U.S. compounding pharmacies, 2-day UPS shipping once you're approved, and 1-on-1 onboarding support to help you get started the right way. TelehealthFX is licensed in all 50 states, so no matter where you're watching from, you can find out if you qualify.   If you're comparing Ozempic alternatives, researching compounded semaglutide or compounded tirzepatide, or just trying to figure out which GLP-1 medication delivered to your door actually makes sense for your goals, this episode walks through the clinical evidence in plain language, no medical degree required.   We also touch on where berberine and other natural options fit for people exploring alternatives to prescription GLP-1 therapy, and why real clinical oversight looks different from a subscription box with a doctor's signature stapled to it.   This content is for educational purposes only and is not a substitute for professional medical advice. Individual results vary. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication or treatment plan discussed in this episode.   Ready to find out which option might be right for you? Take the free qualification quiz now at https://go.telehealthfx.com/start. Curious about berberine as a natural complement or alternative? Check out https://go.telehealthfx.com/berberine. Or explore the full TelehealthFX program, including semaglutide, tirzepatide, NAD+ therapy, and sermorelin, at https://telehealthfx.com.   Subscribe to TelehealthFX Talk for new episodes covering GLP-1 medications, telehealth weight loss programs, compounded medication safety, and the science behind sustainable weight management. New episodes drop regularly, and we're always digging into the questions our listeners are actually searching for, so drop your topic requests in the comments below.   Quick FAQ from this episode:   Is Zepbound stronger than Wegovy? In head-to-head trial data, tirzepatide (Zepbound) produced a larger average percentage of body weight loss than semaglutide (Wegovy) over 72 weeks. "Stronger" isn't the same as "better for you" though — side-effect tolerance and existing health conditions matter just as much as the topline number.   Does Wegovy or Zepbound have worse side effects? Trial data shows Wegovy associated with somewhat higher rates of nausea, vomiting, and diarrhea, while Zepbound's GI side effects tend to be more concentrated right after a dose increase.   Is there a pill version of either medication? Yes — an oral version of Wegovy launched in January, giving needle-averse patients a daily tablet option alongside the weekly injection.   Which one is better for heart health? Wegovy has completed cardiovascular outcomes data showing a meaningful reduction in major cardiovascular events for people with existing heart disease. Zepbound's equivalent trial is still ongoing.   Can I get either through telehealth? Many platforms offer semaglutide or tirzepatide, including compounded formulations through licensed U.S. pharmacies, after a clinical intake and provider review. TelehealthFX offers both with transparent pricing and no hidden membership fees.   #GLP1 #WeightLoss #Semaglutide #Tirzepatide #OzempicAlternative #TelehealthWeightLoss #TelehealthFX #CompoundedSemaglutide #WeightLossMedication #Berberine #Dihydroberberine #BerberineWeightLoss #NADTherapy #Sermorelin #Liraglutide #Wegovy #Zepbound #ClinicalWeightLoss #WeightManagement #FatBurning #DietPill #PCOSWeightLoss #InsulinResistance #GLP1ForWeightLoss #WeightLossDelivered #RapidFatLoss #WeightLossForWomen #WeightLossForSeniors #Mounjaro #Ozempic

  6. May 31

    Tirzepatide, Explained: Mounjaro vs. Zepbound, How It Works & Why It's a Sleep Apnea Drug Now

    Learn more or see if you may qualify at https://telehealthfx.com Educational content only — not medical advice. Talk to a licensed clinician before starting any medication. Telehealth FX is an informational and affiliate platform, not a medical provider or pharmacy, and may earn a commission. Compounded medications are not FDA-approved. Individual results vary. Tirzepatide is the medication behind Mounjaro and Zepbound — and unlike single-receptor GLP-1s, it's a dual GIP/GLP-1 agonist. In this episode we explain what tirzepatide is, how the two-receptor mechanism works, the difference between the brands, what the research shows for weight and blood sugar, how it compares to semaglutide, and why it recently became the first medication ever approved for obstructive sleep apnea — plus the real side effects and the honest truth about stopping. Quick clarifier: tirzepatide is the active drug. Mounjaro is approved for type 2 diabetes; Zepbound is approved for weight management and, as of December 2024, for moderate-to-severe obstructive sleep apnea in adults with obesity. Key facts: In SURMOUNT-1, average weight loss ranged from about 16% to 22.5% over 72 weeks. In the head-to-head SURMOUNT-5 trial, tirzepatide produced about 20.2% weight loss versus 13.7% for semaglutide. In SURMOUNT-OSA, the highest tolerated doses were associated with roughly 25–29 fewer apnea/hypopnea events per hour versus placebo. Across follow-up studies, people regained roughly two-thirds of lost weight within a year of stopping. Real risks discussed: gastrointestinal side effects; a boxed warning for thyroid C-cell tumors (not for those with a personal/family history of medullary thyroid carcinoma or MEN2); pancreatitis and gallbladder risks; a class warning for ileus (intestinal blockage). Note: a large analysis did not find a significant link between tirzepatide and the rare optic-nerve condition associated with semaglutide, though research continues. Important: Compounded tirzepatide is not FDA-approved — the FDA does not evaluate it for safety, effectiveness, or quality — and it is not the same as branded Mounjaro or Zepbound. Prescription medications require evaluation and a prescription from a licensed clinician, and eligibility is individual. Individual results vary. Learn more or see if you may qualify at https://telehealthfx.com #Tirzepatide #Mounjaro #Zepbound #WeightManagement #SleepApnea #GLP1 #HealthEducation #Telehealth

  7. May 31

    Semaglutide, Explained: Ozempic vs. Wegovy vs. the New Pill, Side Effects & How It Works

    Viit https://telehealthfx.com to get started. Educational content only — not medical advice. Talk to a licensed clinician before starting any medication. Telehealth FX is an informational and affiliate platform, not a medical provider or pharmacy, and may earn a commission. Compounded medications are not FDA-approved. Individual results vary. Semaglutide goes by a lot of names — Ozempic, Wegovy, Rybelsus, and now the new Wegovy pill — and the confusion is real. In this episode we explain what semaglutide actually is, how it works, the difference between the brands, how well it works for weight management, what the research says about heart health, how it compares to tirzepatide, the real side effects, and the honest truth about what happens when you stop. Quick clarifier: semaglutide is the active drug. Ozempic is the injection approved for type 2 diabetes; Wegovy is the injection approved for weight management; Rybelsus is the oral tablet for type 2 diabetes. In December 2025 the FDA approved a once-daily oral semaglutide (Wegovy pill) for chronic weight management. Key facts: In the STEP 1 trial, average weight loss with semaglutide 2.4 mg injection was about 14.9% over 68 weeks. In the OASIS 4 trial, the oral 25 mg pill produced about 13.6% average weight loss (around 16.6% with full adherence), described as similar to the injection. In the SELECT trial, semaglutide was linked to about a 20% reduction in major cardiovascular events in people with overweight/obesity and established heart disease. In the head-to-head SURMOUNT-5 trial, semaglutide produced about 13.7% weight loss versus 20.2% for tirzepatide. Across follow-up studies, people regained roughly two-thirds of lost weight within a year of stopping. Real risks discussed: gastrointestinal side effects; a boxed warning for thyroid C-cell tumors (not for those with a personal/family history of medullary thyroid carcinoma or MEN2); pancreatitis and gallbladder risks; and an eye-condition signal still under study. Important: Compounded semaglutide is not FDA-approved — the FDA does not evaluate it for safety, effectiveness, or quality — and it is not the same as branded Ozempic or Wegovy. Prescription medications require evaluation and a prescription from a licensed clinician, and eligibility is individual. Individual results vary. Learn more or see if you may qualify at https://telehealthfx.com #Semaglutide #Ozempic #Wegovy #Rybelsus #WeightManagement #GLP1 #HealthEducation #Telehealth

  8. May 31

    How Well Do GLP-1s Actually Work? Semaglutide, Tirzepatide & the New Pill, Explained

    Visit https://losingweightrx.com to get started. Educational content only — not medical advice. Talk to a licensed clinician before starting any medication. Telehealth FX is an informational and affiliate platform, not a medical provider or pharmacy, and may earn a commission. Compounded medications are not FDA-approved. Individual results vary. In this episode we look at what the science actually says about how well GLP-1 medications work for weight management — and what "effective" really means once you look past the first few months. We cover how semaglutide and tirzepatide work, the headline results from the major clinical trials, the newly approved any-time-of-day GLP-1 pill, the cardiovascular findings that go beyond the scale, and the honest catch most ads skip: these medications work while you take them, and much of the lost weight tends to return after stopping. Key facts: In the STEP 1 trial, average weight loss with semaglutide 2.4 mg was about 14.9% over 68 weeks. In SURMOUNT-1, tirzepatide produced roughly 16–22% average loss depending on dose. In the SELECT trial, semaglutide was linked to about a 20% reduction in major cardiovascular events in people with overweight/obesity and established heart disease. The newly approved oral GLP-1 showed up to about 12.4% weight loss at its highest dose over 72 weeks. Across follow-up studies, people regained roughly two-thirds of lost weight within a year of stopping. Real risks discussed: gastrointestinal side effects; a boxed warning for thyroid C-cell tumors (not for those with a personal/family history of medullary thyroid carcinoma or MEN2); pancreatitis and gallbladder risks; and an eye-condition signal still under study. Important: Compounded semaglutide and tirzepatide are not FDA-approved — the FDA does not evaluate them for safety, effectiveness, or quality — and they are not the same as branded Ozempic, Wegovy, Mounjaro, or Zepbound. Prescription medications require evaluation and a prescription from a licensed clinician, and eligibility is individual. Individual results vary. Learn more or see if you may qualify at https://telehealthfx.com #GLP1 #Semaglutide #Tirzepatide #WeightManagement #ObesityMedicine #HealthEducation #Telehealth

See All (47)

About

Welcome to TelehealthFX Talk, the evidence-based podcast that cuts through the hype of the rapidly evolving world of clinical weight loss and metabolic medicine.Whether you are navigating the transition to GLP-1 medications like semaglutide and tirzepatide, exploring complementary therapies like sermorelin and NAD+, or looking for natural metabolic support with berberine, we provide the honest, research-backed science you need to make informed decisions. Each week, we break down complex topics—from managing side effects and breaking through weight loss plateaus to preserving lean muscle mass and understanding the latest FDA updates.It is time to silence the food noise and optimize your metabolic health. Hit subscribe to stay up-to-date with the latest breakthroughs in clinical wellness, and visit us at telehealthfx.com to learn more about our comprehensive clinical programs.

Information

You Might Also Like